Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-27 | During 2021, Dr. Royston was an employee and executive officer of the company and therefore did not receive compensation as a director. See Executive Compensation for additional information regarding Dr. Royston’s compensation. |
| 2023-04-27 | Dr. Royston served as Chief Executive Officer, President, and a member of the board of directors from the closing of the Merger in February 2021 until September 2022, from which time Dr. Royston has continued to serve as a Director. Member of science and technology committee. Dr. Royston was an employee and did not receive director compensation while employed. |
| 2024-04-26 | Dr. Royston served as Chief Executive Officer, President, and a member of the board of directors from February 2021 until September 2022, from which time Dr. Royston has continued to serve as a Director. ... Dr. Royston received his B.A. and M.D. degrees from Johns Hopkins University and completed post-doctoral training in internal medicine and medical oncology at Stanford University. ... The following table sets forth information regarding the total compensation awarded to, earned by or paid to our non-employee directors for their service on our board of directors, for the fiscal year ended December 31, 2023. ... Ivor Royston, M.D. Fees Paid or Earned in Cash ($) 45,000 Option Awards($) 45,755 Total ($) 90,755 ... The current members of our science and technology committee are Dr. Borellini, Dr. Murphy, Dr. Royston and Dr. Rubino. |
Data sourced from SEC filings. Last updated: 2026-03-09